Works matching AU Hidaka, Hisashi


Results: 79
    1
    2

    Esophageal Varices as an Independent Predictor of Fatal Outcomes after Balloon-Occluded Retrograde Transvenous Obliteration in Patients with Hepatic Encephalopathy.

    Published in:
    Digestive Diseases, 2024, v. 42, n. 6, p. 583, doi. 10.1159/000541660
    By:
    • Iwasaki, Shuichiro;
    • Uojima, Haruki;
    • Sakita, Shinya;
    • Masuda, Sakue;
    • Kubota, Kousuke;
    • Fujikawa, Tomoaki;
    • Okubo, Tomomi;
    • Setsu, Toru;
    • Itokawa, Norio;
    • Furuichi, Yoshihiro;
    • Arase, Yoshitaka;
    • Tukiyama, Toshiki;
    • Fujii, Kaoru;
    • Hidaka, Hisashi;
    • Atsukawa, Masanori;
    • Kagawa, Tatehiro;
    • Kako, Makoto;
    • Terai, Shuji;
    • Kusano, Chika
    Publication type:
    Article
    3
    4

    The Risk of Cirrhosis and Its Complications Based on PNPLA3 rs738409 G Allele Frequency.

    Published in:
    Digestive Diseases, 2022, v. 40, n. 5, p. 625, doi. 10.1159/000521062
    By:
    • Shao, Xue;
    • Uojima, Haruki;
    • Arai, Taeang;
    • Ogawa, Yuji;
    • Setsu, Toru;
    • Atsukawa, Masanori;
    • Furuichi, Yoshihiro;
    • Arase, Yoshitaka;
    • Horio, Kazue;
    • Hidaka, Hisashi;
    • Nakazawa, Takahide;
    • Kako, Makoto;
    • Kagawa, Tatehiro;
    • Iwakiri, Katsuhiko;
    • Nakajima, Atsushi;
    • Terai, Shuji;
    • Tanaka, Yasuhito;
    • Koizumi, Wasaburo
    Publication type:
    Article
    5
    6

    Impact of Anti-GPIIb/IIIa Antibody-Producing B Cells as a Predictor of the Response to Lusutrombopag in Thrombocytopenic Patients with Liver Disease.

    Published in:
    Digestive Diseases, 2021, v. 39, n. 3, p. 234, doi. 10.1159/000510692
    By:
    • Wada, Naohisa;
    • Uojima, Haruki;
    • Satoh, Takashi;
    • Okina, Sosei;
    • Iwasaki, Shuichiro;
    • Shao, Xue;
    • Takiguchi, Hayato;
    • Arase, Yoshitaka;
    • Itokawa, Norio;
    • Atsukawa, Masanori;
    • Miyazaki, Koji;
    • Hidaka, Hisashi;
    • Kako, Makoto;
    • Kagawa, Tatehiro;
    • Iwakiri, Katsuhiko;
    • Horie, Ryouichi;
    • Suzuki, Takahiro;
    • Koizumi, Wasaburo
    Publication type:
    Article
    7
    8
    9

    Comparative study between sorafenib and lenvatinib as the first‐line therapy in the sequential treatment of unresectable hepatocellular carcinoma in a real‐world setting.

    Published in:
    JGH Open, 2022, v. 6, n. 1, p. 29, doi. 10.1002/jgh3.12691
    By:
    • Fukushima, Taito;
    • Morimoto, Manabu;
    • Ueno, Makoto;
    • Kubota, Kousuke;
    • Uojima, Haruki;
    • Hidaka, Hisashi;
    • Chuma, Makoto;
    • Numata, Kazushi;
    • Tsuruya, Kota;
    • Hirose, Shunji;
    • Kagawa, Tatehiro;
    • Hattori, Nobuhiro;
    • Watanabe, Tsunamasa;
    • Matsunaga, Kotaro;
    • Yamamoto, Kouji;
    • Tanaka, Katsuaki;
    • Maeda, Shin
    Publication type:
    Article
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21

    Lenvatinib radiofrequency ablation sequential therapy offers survival benefits for patients with unresectable hepatocellular carcinoma at intermediate stage and the liver reserve of Child–Pugh A category: A multicenter study.

    Published in:
    Hepatology Research, 2024, v. 54, n. 12, p. 1174, doi. 10.1111/hepr.14089
    By:
    • Zhang, Ying;
    • Numata, Kazushi;
    • Imajo, Kento;
    • Uojima, Haruki;
    • Funaoka, Akihiro;
    • Komiyama, Satoshi;
    • Ogushi, Katsuaki;
    • Chuma, Makoto;
    • Irie, Kuniyasu;
    • Kokubu, Shigehiro;
    • Yoneda, Masato;
    • Kobayashi, Takashi;
    • Hidaka, Hisashi;
    • Fukushima, Taito;
    • Kobayashi, Satoshi;
    • Morimoto, Manabu;
    • Kagawa, Tatehiro;
    • Hattori, Nobuhiro;
    • Watanabe, Tsunamasa;
    • Iwase, Shigeru
    Publication type:
    Article
    22

    Guidelines for the diagnosis and treatment of idiopathic portal hypertension, extrahepatic portal obstruction, and Budd–Chiari syndrome in Japan.

    Published in:
    Hepatology Research, 2024, v. 54, n. 11, p. 952, doi. 10.1111/hepr.14118
    By:
    • Furuichi, Yoshihiro;
    • Kage, Masayoshi;
    • Ohta, Masayuki;
    • Ohfuji, Satoko;
    • Sasaki, Hideyuki;
    • Hidaka, Hisashi;
    • Yoshida, Hiroshi;
    • Kanto, Tatsuya;
    • Kusano, Hironori;
    • Akahoshi, Tomohiko;
    • Obara, Katsutoshi;
    • Hashizume, Makoto;
    • Kuniyoshi, Yukio;
    • Kawaguchi, Takumi;
    • Okubo, Hironao;
    • Ishikawa, Tsuyoshi;
    • Hirooka, Masashi;
    • Iwakiri, Yasuko;
    • Nio, Masaki;
    • Tanaka, Atsushi
    Publication type:
    Article
    23
    24

    Clinical outcomes of antithrombin III‐based therapy for patients with portal vein thrombosis: A retrospective, multicenter study.

    Published in:
    Hepatology Research, 2023, v. 53, n. 1, p. 51, doi. 10.1111/hepr.13840
    By:
    • Hayama, Korenobu;
    • Atsukawa, Masanori;
    • Tsubota, Akihito;
    • Kondo, Chisa;
    • Iwasa, Motoh;
    • Hasegawa, Hiroshi;
    • Takaguchi, Koichi;
    • Tsutsui, Akemi;
    • Uojima, Haruki;
    • Hidaka, Hisashi;
    • Okubo, Hironao;
    • Suzuki, Tatsuya;
    • Matsuura, Kentaro;
    • Tada, Toshifumi;
    • Kawabe, Naoto;
    • Tani, Joji;
    • Morishita, Asahiro;
    • Ishikawa, Toru;
    • Arase, Yoshitaka;
    • Furuichi, Yoshihiro
    Publication type:
    Article
    25
    26

    Evidence‐based clinical practice guidelines for liver cirrhosis 2020.

    Published in:
    Hepatology Research, 2021, v. 51, n. 7, p. 725, doi. 10.1111/hepr.13678
    By:
    • Yoshiji, Hitoshi;
    • Nagoshi, Sumiko;
    • Akahane, Takemi;
    • Asaoka, Yoshinari;
    • Ueno, Yoshiyuki;
    • Ogawa, Koji;
    • Kawaguchi, Takumi;
    • Kurosaki, Masayuki;
    • Sakaida, Isao;
    • Shimizu, Masahito;
    • Taniai, Makiko;
    • Terai, Shuji;
    • Nishikawa, Hiroki;
    • Hiasa, Yoichi;
    • Hidaka, Hisashi;
    • Miwa, Hiroto;
    • Chayama, Kazuaki;
    • Enomoto, Nobuyuki;
    • Shimosegawa, Tooru;
    • Takehara, Tetsuo
    Publication type:
    Article
    27

    Analysis of efficacy of lenvatinib treatment in highly advanced hepatocellular carcinoma with tumor thrombus in the main trunk of the portal vein or tumor with more than 50% liver occupation: A multicenter analysis.

    Published in:
    Hepatology Research, 2021, v. 51, n. 2, p. 201, doi. 10.1111/hepr.13592
    By:
    • Chuma, Makoto;
    • Uojima, Haruki;
    • Hiraoka, Atsushi;
    • Kobayashi, Satoshi;
    • Toyoda, Hidenori;
    • Tada, Toshifumi;
    • Hidaka, Hisashi;
    • Iwabuchi, Shogo;
    • Numata, Kazushi;
    • Itobayashi, Ei;
    • Itokawa, Norio;
    • Kariyama, Kazuya;
    • Ohama, Hideko;
    • Hattori, Nobuhiro;
    • Hirose, Shunji;
    • Shibata, Hiroshi;
    • Tani, Joji;
    • Imai, Michitaka;
    • Tajiri, Kazuto;
    • Moriya, Satoshi
    Publication type:
    Article
    28
    29
    30

    Risk factors for loss of skeletal muscle mass in patients with cirrhosis.

    Published in:
    Hepatology Research, 2019, v. 49, n. 5, p. 550, doi. 10.1111/hepr.13308
    By:
    • Sung, Ji Hyun;
    • Uojima, Haruki;
    • Hidaka, Hisashi;
    • Tanaka, Yoshiaki;
    • Wada, Naohisa;
    • Kubota, Kousuke;
    • Nakazawa, Takahide;
    • Shibuya, Akitaka;
    • Fujikawa, Tomoaki;
    • Yamanoue, Hiroki;
    • Kako, Makoto;
    • Koizumi, Wasaburo
    Publication type:
    Article
    31

    Reply from the authors.

    Published in:
    Hepatology Research, 2018, v. 48, n. 3, p. E381, doi. 10.1111/hepr.13003
    By:
    • Hidaka, Hisashi;
    • Kokubu, Shigehiro
    Publication type:
    Article
    32
    33

    Prospective, randomized, controlled study of the efficacy of transcatheter arterial chemoembolization with miriplatin for hepatocellular carcinoma.

    Published in:
    Hepatology Research, 2018, v. 48, n. 3, p. E98, doi. 10.1111/hepr.12933
    By:
    • Kubota, Kousuke;
    • Hidaka, Hisashi;
    • Nakazawa, Takahide;
    • Okuwaki, Yusuke;
    • Yamane, Keiko;
    • Inoue, Tomoyoshi;
    • Uojima, Haruki;
    • Takada, Juichi;
    • Tanaka, Yoshiaki;
    • Shibuya, Akitaka;
    • Fujii, Kaoru;
    • Woodhams, Reiko;
    • Matsunaga, Keiji;
    • Kokubu, Shigehiro;
    • Koizumi, Wasaburo
    Publication type:
    Article
    34

    Superparamagnetic iron oxide-enhanced magnetic resonance imaging is useful in predicting malignant potential of vascular transformation of hypointense hypovascular nodules on gadoxetic acid-enhanced magnetic resonance imaging.

    Published in:
    Hepatology Research, 2017, v. 47, n. 11, p. 1118, doi. 10.1111/hepr.12850
    By:
    • Tanaka, Yoshiaki;
    • Nakazawa, Takahide;
    • Inoue, Tomoyoshi;
    • Yamane, Keiko;
    • Kubota, Kousuke;
    • Uojima, Haruki;
    • Takada, Juichi;
    • Okuwaki, Yusuke;
    • Hidaka, Hisashi;
    • Shibuya, Akitaka;
    • Kokubu, Shigehiro;
    • Matsunaga, Keiji;
    • Koizumi, Wasaburo
    Publication type:
    Article
    35
    36
    37
    38
    39
    40

    Reliability and validity of splenic volume measurement by 3-D ultrasound.

    Published in:
    Hepatology Research, 2010, v. 40, n. 10, p. 979, doi. 10.1111/j.1872-034X.2010.00705.x
    By:
    • Hidaka, Hisashi;
    • Nakazawa, Takahide;
    • Wang, Guoqin;
    • Kokubu, Shigehiro;
    • Minamino, Tsutomu;
    • Takada, Juichi;
    • Tanaka, Yoshiaki;
    • Okuwaki, Yusuke;
    • Watanabe, Masaaki;
    • Shibuya, Akitaka;
    • Koizumi, Wasaburo
    Publication type:
    Article
    41
    42
    43
    44
    45
    46
    47

    Hepatic arterial infusion chemotherapy with cisplatin and sorafenib in hepatocellular carcinoma patients unresponsive to transarterial chemoembolization: A propensity score-based weighting.

    Published in:
    Journal of Digestive Diseases, 2015, v. 16, n. 3, p. 143, doi. 10.1111/1751-2980.12221
    By:
    • Kondo, Masaaki;
    • Morimoto, Manabu;
    • Ishii, Tomohiro;
    • Nozaki, Akito;
    • Fukuda, Hiroyuki;
    • Numata, Kazushi;
    • Kobayashi, Satoshi;
    • Ohkawa, Shinichi;
    • Hidaka, Hisashi;
    • Nakazawa, Takahide;
    • Shibuya, Akitaka;
    • Okuse, Chiaki;
    • Suzuki, Michihiro;
    • Sakamaki, Kentaro;
    • Morita, Satoshi;
    • Maeda, Shin;
    • Tanaka, Katsuaki
    Publication type:
    Article
    48
    49

    Progression pattern and post‐progression survival following atezolizumab and bevacizumab treatment in advanced hepatocellular carcinoma.

    Published in:
    Liver International, 2024, v. 44, n. 6, p. 1343, doi. 10.1111/liv.15825
    By:
    • Kobayashi, Satoshi;
    • Fukushima, Taito;
    • Ueno, Makoto;
    • Chuma, Makoto;
    • Numata, Kazushi;
    • Tsuruya, Kota;
    • Arase, Yoshitaka;
    • Hirose, Shunji;
    • Kagawa, Tatehiro;
    • Hattori, Nobuhiro;
    • Watanabe, Tsunamasa;
    • Matsunaga, Kotaro;
    • Uojima, Haruki;
    • Hidaka, Hisashi;
    • Kusano, Chika;
    • Morimoto, Manabu;
    • Maeda, Shin
    Publication type:
    Article
    50

    Re-appearance of hepatitis B virus following therapy with rituximab for lymphoma is not rare in Japanese patients with past hepatitis B virus infection.

    Published in:
    Liver International, 2011, v. 31, n. 3, p. 340, doi. 10.1111/j.1478-3231.2010.02417.x
    By:
    • Watanabe, Masaaki;
    • Shibuya, Akitaka;
    • Tsunoda, Yuhko;
    • Danbara, Mikio;
    • Ishii, Ryuji;
    • Ohsaka, Manabu;
    • Takada, Juichi;
    • Tanaka, Yoshiaki;
    • Okuwaki, Yusuke;
    • Minamino, Tsutomu;
    • Hidaka, Hisashi;
    • Nakazawa, Takahide;
    • Horie, Ryouichi;
    • Higashihara, Masaaki;
    • Koizumi, Wasaburo
    Publication type:
    Article